Week of April 14 - 20, 2019
Trastuzumab-dttb (Ontruzant®) is a biosimilar monoclonal antibody used in the treatment of some types of breast and gastric cancer.
In this webinar, Dr. Neil Taunk, MD, MS, Assistant Professor and Chief of Gynecologic Radiation Oncology at Penn Medicine, provides an overview of proton radiation therapy for gynecologic cancers.
Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta™) is a medication used in the treatment of some cases of breast cancer.
This webinar provides an overview of proton therapy to treatment spine tumors.
This section contains articles that explain the different types of blood products, and how and why they are transfused.
Calaspargase pegol-mknl (Asparlas™) is an antineoplastic enzyme used in the treatment of some cases of acute lymphoblastic leukemia.
Trastuzumab-pkrb (Herzuma®) is monoclonal antibody biosimilar used in the treatment of some types of breast cancer.
This article provides an overview of iron deficiency anemia-its symptoms, risk factors, diagnosis and treatment.
Ginger can be helpful in managing some cancer related symptoms including nausea, vomiting, muscle pain and dizziness. This article provides an overview of how to use ginger as well as dietary recommendations.
This article provides tips for eating small meals and snacks throughout the day during cancer treatment which can help manage treatment and disease related symptoms.
Larotrectinib (Vitrakvi®) is a kinase inhibitor used in the treatment of certain adult and pediatric solid tumors with certain neurotrophic receptor kinase (NTRK) genes.
Rituximab-abbs (Truxima®) is a biosimilar, monoclonal antibody used in the treatment of non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL).
Lauren Clanet, RD, presents a video showing you how to make two different protein packed purees. She also includes the recipes.
Glasdegib (Daurismo™) is a hedgehog pathway inhibitor used in the treatment of AML in patients 75 years or older in combination with low dose cytarabine.
Gilteritinib (Xospata®) is a kinase inhibitor used in the treatment of acute leukemia with a mutation in the FTL3 gene.
This article provides an overview of measurable/minimal residual (MRD) testing and its use in treatment planning for ALL, lymphoma and multiple myeloma.
Lorlatinib (Lorbrena®) is a tyrosine kinase inhibitor (TKI) used in the treatment of progressive, metastatic non small cell lung cancer.
Talazoparib (Talzenna™) is a PARP inhibitor used in the treatment of some types of breast cancer.